Cancer cures won't reach patients if Pelosi's drug bill passes

House Democrats recently unveiled H.R. 3, a sweeping proposal that would impose a slew of ill-considered price controls on prescription drugs — and a virtual death knell on innovation

Not surprisingly, patient advocates immediately panned the bill, warning that it would deter medical research and thus prevent scientists from developing ...